Valirx (VAL) RNS Announcements

Add to Alert list
Date Time Source Announcement
18 Oct 2021 02:01 PM
RNS
Price Monitoring Extension
18 Oct 2021 11:06 AM
RNS
Second Price Monitoring Extn
18 Oct 2021 11:00 AM
RNS
Price Monitoring Extension
30 Sep 2021 02:45 PM
RNS
Holding(s) in Company
30 Sep 2021 12:24 PM
RNS
Holding(s) in Company
28 Sep 2021 04:41 PM
RNS
Second Price Monitoring Extn
28 Sep 2021 04:36 PM
RNS
Price Monitoring Extension
17 Sep 2021 04:41 PM
RNS
Second Price Monitoring Extn
17 Sep 2021 04:36 PM
RNS
Price Monitoring Extension
16 Sep 2021 07:00 AM
RNS
New Evaluation Agreement
08 Sep 2021 07:00 AM
RNS
Holding(s) in Company
07 Sep 2021 07:00 AM
RNS
Half-year Report
25 Aug 2021 07:00 AM
RNS
Appointment of Broker
20 Aug 2021 02:05 PM
RNS
Second Price Monitoring Extn
20 Aug 2021 02:00 PM
RNS
Price Monitoring Extension
06 Jul 2021 07:00 AM
RNS
Patent update
17 Jun 2021 04:40 PM
RNS
Second Price Monitoring Extn
17 Jun 2021 04:35 PM
RNS
Price Monitoring Extension
27 May 2021 12:48 PM
RNS
Result of AGM
27 May 2021 07:00 AM
RNS
KTH222 Evaluation Agreement Concluded
30 Apr 2021 12:00 PM
RNS
Posting of Annual Report and Notice of AGM
27 Apr 2021 07:00 AM
RNS
Final Results
01 Mar 2021 07:00 AM
RNS
Total Voting Rights
25 Feb 2021 07:00 AM
RNS
Block listing Interim Review
18 Feb 2021 03:39 PM
RNS
Director/PDMR Shareholding
15 Feb 2021 07:00 AM
RNS
Extension of Collaboration Agreement
19 Jan 2021 11:36 AM
RNS
Director Disclosure
19 Jan 2021 07:00 AM
RNS
Patent Status Update
30 Nov 2020 11:04 AM
RNS
Holding(s) in Company
30 Nov 2020 07:46 AM
RNS
VAL201 Clinical Trial Full Data Results
10 Nov 2020 07:00 AM
RNS
Agreement with Kalos Therapeutics
02 Nov 2020 07:00 AM
RNS
Total Voting Rights and Block Listing Update
16 Oct 2020 11:05 AM
RNS
Second Price Monitoring Extn
16 Oct 2020 11:00 AM
RNS
Price Monitoring Extension
02 Oct 2020 04:00 PM
RNS
Exercise of Warrant
01 Oct 2020 07:00 AM
RNS
Total Voting Rights and Block Listing Update
30 Sep 2020 10:34 AM
RNS
Holding(s) in Company
29 Sep 2020 04:13 PM
RNS
Holding(s) in Company
29 Sep 2020 07:00 AM
RNS
Exercise of Warrant
28 Sep 2020 04:41 PM
RNS
Second Price Monitoring Extn
28 Sep 2020 04:35 PM
RNS
Price Monitoring Extension
28 Sep 2020 07:00 AM
RNS
VAL201 Clinical Trial Update
25 Sep 2020 04:41 PM
RNS
Second Price Monitoring Extn
25 Sep 2020 04:36 PM
RNS
Price Monitoring Extension
25 Sep 2020 11:55 AM
RNS
Holding(s) in Company
24 Sep 2020 11:05 AM
RNS
Second Price Monitoring Extn
24 Sep 2020 11:00 AM
RNS
Price Monitoring Extension
23 Sep 2020 12:39 PM
RNS
Holding(s) in Company
23 Sep 2020 07:06 AM
RNS
Second Price Monitoring Extn
23 Sep 2020 07:04 AM
RNS
Price Monitoring Extension

ValiRx PLC: A Biotech Innovator on the London Stock Exchange (LSE)

ValiRx PLC, known by its ticker symbol VAL, is a trailblazer in the biotechnology sector. Its performance on the London Stock Exchange (LSE) has been remarkable, with the ValiRx share price reflecting the company's consistent growth and success.

As a member of the LSE, ValiRx PLC aligns with the London Stock Exchange Group's (LSEG) mission of supporting innovative and growing businesses. The LSEG recognises ValiRx PLC as a significant player, contributing to the robust and diverse ecosystem of the LSE.

The ValiRx share price on the LSE not only underscores its financial stability but also its strategic vision in the biotechnology industry. ValiRx PLC's journey on the LSE is a testament to its robust business model and its ability to create value for its stakeholders.

In conclusion, ValiRx PLC's association with the LSE and LSEG symbolises its commitment to growth, innovation, and value creation. As ValiRx PLC continues to thrive on the LSE, it sets the bar high for the biotechnology industry, contributing to the dynamic and diverse ecosystem of the LSEG. With its focus on cancer therapeutics, ValiRx is a key player in the healthcare sector, making strides in medical research and development.

UK 100

Latest directors dealings